Menu

Activity Detail

Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and latest CE information More Information

Featured Activity

This activity will cover key topics of interest to stakeholders who set practice policy and will be called upon to evaluate and make decisions on issues pertaining to biosimilars.

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

HIDE SEARCH

Adult Pneumococcal Vaccinations: The Vital Role of the Pharmacist in Improving Outcomes

Activity Downloads

To Participate

To participate in this continuing education activity:

  1. Review the activity description and objectives.
  2. View the activity.
  3. Complete the online post-test and activity evaluation.
A product of the Society of Infectious Diseases Pharmacists Education Center (SIDPEC) 

 
 View more SIDPEC Activities
 

NOTE: If you attended the live CE webinar titled "Adult Pneumococcal Vaccinations: The Vital Role of the Pharmacist in Improving Outcomes" that was held on October 27 and November 2, 2016, AND received CE credit (i.e. a pharmacist CE statement with ACPE Universal Activity Number 0221-9999-16-323-L01-P), you are NOT eligible to also receive CE credit for this home-study activity.

Description

Every year in the U.S., pneumococcal disease kills thousands of adults, and many more end up hospitalized, yet vaccination rates lag behind public health standards. Pharmacists are in a strong position to ensure that those adults of highest need receive timely vaccination according to the most recent national recommendations.

This activity will provide you with strategies for improving vaccination rates in eligible patients and underserved populations, as well as tactics for overcoming common barriers to improve outcomes and reduce the high burden of this disease on the health system. Expert faculty will present case scenarios.

Learning Objectives

The target audience for this activity includes pharmacists working in community, long-term care and health-system settings. At the completion of this webinar, the participant will be able to:

  • Describe the incidence of and morbidity and mortality associated with pneumococcal disease in elderly and high-risk patients.
  • Review current pneumococcal immunization recommendations and schedules in eligible adults.
  • Discuss the pharmacology, cost-effectiveness and adverse effects of pneumococcal vaccines.
  • Explain strategies by which pharmacists may improve pneumococcal vaccination rates in a variety of health care settings and how outcomes may be measured.
  • Describe ways in which pharmacists may reduce the burden of pneumococcal disease and promote antimicrobial stewardship through improved immunization programs.

Faculty

Paul O. Gubbins, PharmD
Associate Dean, Missouri State University
Vice Chair & Professor, Division of Pharmacy Practice & Administration
University of Missouri-Kansas City School of Pharmacy at MSU
Kansas City, Missouri

Michael E. Klepser, PharmD, FCCP
Professor of Pharmacy Practice
Ferris State University
College of Pharmacy
Big Rapids, Michigan

Accreditation

Release Date: 10-27-2016
Expiration Date: 12-31-2017

Pharmacists

ACPE LogoThis activity is jointly provided by ProCE, Inc. and the Society of Infectious Diseases Pharmacists. ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-16-323-H01-P has been assigned to this home-study knowledge-based activity (initial release date October 27, 2016). This activity is approved for 1.0 contact hours (0.1 CEUs) in states that recognize ACPE providers. The activity is provided at no cost to participants. Participants must complete the online post-test and activity evaluation to receive pharmacy CE credit. No partial credit will be given. Statements of completion will be issued online at www.ProCE.com, and proof of completion will be posted in NABP CPE Monitor profiles.

Disclosure

It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed in this activity. Dr. Gubbins has no relevant commercial or financial relationships to disclose. Dr. Klepser has no relevant commercial or financial relationships to disclose. A portion of grant funds received by ProCE from Pfizer Inc. will be used to compensate the faculty for this presentation.

Please note: The information and views presented in this activity are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs and/or devices for unlabeled indications, which should be considered experimental. Participants are advised to consult manufacturer product information and the professional literature, and use professional judgment in applying the presented information in patient-care activities.

Funding

This activity is supported by an educational grant from Pfizer Inc.

The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.